Cargando…

SUMOylation of Smad2 mediates TGF-β-regulated endothelial–mesenchymal transition

Endothelial–mesenchymal transition (EndoMT) is a complex biological process in which endothelial cells are transformed into mesenchymal cells, and dysregulated EndoMT causes a variety of pathological processes. Transforming growth factor beta (TGF-β) signaling effectively induces the EndoMT process...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Qi, Chen, Xu, Ling, Xing, Li, Danqing, Ren, Xiang, Zhao, Yang, Yang, Yanyan, Liu, Yuhang, He, Anqi, Zhu, Xinjie, Yang, Xinyi, Lu, Wenbin, Wu, Hongmei, Qi, Yitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570702/ https://www.ncbi.nlm.nih.gov/pubmed/37690680 http://dx.doi.org/10.1016/j.jbc.2023.105244

Ejemplares similares

SUMOylation Wrestles With the Occurrence and Development of Breast Cancer
por: Qin, Yuanyuan, et al.
Publicado: (2021)

Hyper-SUMOylation of ERG Is Essential for the Progression of Acute Myeloid Leukemia
por: Chen, Xu, et al.
Publicado: (2021)

Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition
por: Jin, Ya-Ge, et al.
Publicado: (2017)

The Function of SUMOylation and Its Critical Roles in Cardiovascular Diseases and Potential Clinical Implications
por: Du, Congcong, et al.
Publicado: (2021)

Losartan Attenuates Myocardial Endothelial-To-Mesenchymal Transition in Spontaneous Hypertensive Rats via Inhibiting TGF-β/Smad Signaling
por: Wu, Miao, et al.
Publicado: (2016)

Endothelial Mesenchymal Transition in Hypoxic Microvascular Endothelial Cells and Paracrine Induction of Cardiomyocyte Apoptosis Are Mediated via TGFβ(1)/SMAD Signaling
por: Sniegon, Isabella, et al.
Publicado: (2017)

SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation
por: Zhang, Xiaoyan, et al.
Publicado: (2017)

Semaphorin 7A promotes endothelial to mesenchymal transition through ATF3 mediated TGF-β2/Smad signaling
por: Hong, Lei, et al.
Publicado: (2020)

De-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells
por: Ren, Yan-hua, et al.
Publicado: (2014)

Baicalin and puerarin reverse epithelial-mesenchymal transition via the TGF-β1/Smad3 pathway in vitro
por: Wu, Tao, et al.
Publicado: (2018)

RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial-mesenchymal transition through TGF-β/Smad signaling
por: Xiao, Zhaohua, et al.
Publicado: (2020)

Editorial: Role of the SUMOylation in cancer regulation
por: Chen, Xu, et al.
Publicado: (2023)

KRT7 promotes epithelial-mesenchymal transition in ovarian cancer via the TGF-β/Smad2/3 signaling pathway
por: An, Qiang, et al.
Publicado: (2021)

Suppression of ADAM8 attenuates angiotensin II-induced cardiac fibrosis and endothelial-mesenchymal transition via inhibiting TGF-β1/Smad2/Smad3 pathways
por: Yao, Lixia, et al.
Publicado: (2021)

TGF-β/SMAD4-Regulated LncRNA-LINP1 Inhibits Epithelial-Mesenchymal Transition in Lung Cancer
por: Zhang, Chong, et al.
Publicado: (2018)

Catalpol Attenuates Pulmonary Fibrosis by Inhibiting Ang II/AT(1) and TGF-β/Smad-Mediated Epithelial Mesenchymal Transition
por: Yu, Qun, et al.
Publicado: (2022)

MicroRNA-122 inhibits epithelial-mesenchymal transition of hepatic stellate cells induced by the TGF-β1/Smad signaling pathway
por: Cheng, Bianqiao, et al.
Publicado: (2019)

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
por: Pardali, Evangelia, et al.
Publicado: (2017)

CDCA7 promotes TGF‐β‐induced epithelial–mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC
por: Li, Hongyi, et al.
Publicado: (2022)

Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression
por: Ji, Qing, et al.
Publicado: (2015)

HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells
por: Zhang, Feng, et al.
Publicado: (2018)

Loss of N-Myc interactor promotes epithelial-mesenchymal-transition by activation of TGF-β/SMAD signaling
por: Devine, Daniel J., et al.
Publicado: (2013)

Dulaglutide Ameliorates Intrauterine Adhesion by Suppressing Inflammation and Epithelial–Mesenchymal Transition via Inhibiting the TGF-β/Smad2 Signaling Pathway
por: Wang, Yifan, et al.
Publicado: (2023)

Klotho Inhibits Unilateral Ureteral Obstruction-Induced Endothelial-to-Mesenchymal Transition via TGF-β1/Smad2/Snail1 Signaling in Mice
por: Li, Shasha, et al.
Publicado: (2019)

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
por: Ma, Jin, et al.
Publicado: (2020)

Uncarboxylated osteocalcin promotes proliferation and metastasis of MDA-MB-231 cells through TGF-β/SMAD3 signaling pathway
por: Xu, Jiaojiao, et al.
Publicado: (2022)

MnTE-2-PyP Attenuates TGF-β-Induced Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Inhibiting the Smad2/3 Signaling Pathway
por: Yang, Yu, et al.
Publicado: (2019)

[Corrigendum] Thymoquinone inhibits epithelial‑mesenchymal transition in prostate cancer cells by negatively regulating the TGF‑β/Smad2/3 signaling pathway
por: Kou, Bo, et al.
Publicado: (2023)

Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition
por: Sommerova, Lucia, et al.
Publicado: (2017)

Possible involvement of TGF-β-SMAD-mediated epithelial-mesenchymal transition in pro-metastatic property of PAX6
por: Jin, Meng, et al.
Publicado: (2020)

Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer
por: Chen, Hsin-Yuan, et al.
Publicado: (2021)

Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-β/Smad signaling pathway
por: Geng, Jiang, et al.
Publicado: (2014)

Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways
por: Zhou, Xian-Long, et al.
Publicado: (2017)

Role of SUMOylation of STAT1 in tubular epithelial-mesenchymal transition induced by high glucose
por: Gu, Cunyang, et al.
Publicado: (2023)

Lovastatin Alleviates Endothelial-to-Mesenchymal Transition in Glomeruli via Suppression of Oxidative Stress and TGF-β1 Signaling
por: Ma, Zejun, et al.
Publicado: (2017)

MicroRNA-181a promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma via the TGF-β/Smad pathway
por: Xu, Run, et al.
Publicado: (2021)

NR4A1 inhibits the epithelial–mesenchymal transition of hepatic stellate cells: Involvement of TGF-β–Smad2/3/4–ZEB signaling
por: Huang, Qian, et al.
Publicado: (2022)

Histone modification of endothelial-mesenchymal transition in cardiovascular diseases
por: Jun, Qiu, et al.
Publicado: (2022)

Roles of TGF-β Signals in Endothelial-Mesenchymal Transition during Cardiac Fibrosis
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2011)

Regulation of TGF-β-mediated endothelial-mesenchymal transition by microRNA-27
por: Suzuki, Hiroshi I., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r3i2ldg03m6shd7idqrsfg7trj